Cite
MLA Citation
M. O'Donoghue et al.. “Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial.” Atherosclerosis, vol. 275, 2018, pp. e9–e10. http://access.bl.uk/ark:/81055/vdc_100066563901.0x000058
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
M. O'Donoghue et al.. “Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial.” Atherosclerosis, vol. 275, 2018, pp. e9–e10. http://access.bl.uk/ark:/81055/vdc_100066563901.0x000058